Clinical trials
Phase 3 trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2,012 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 7 |
| 2002 | 8 |
| 2003 | 23 |
| 2004 | 20 |
| 2005 | 24 |
| 2006 | 46 |
| 2007 | 49 |
| 2008 | 72 |
| 2009 | 61 |
| 2010 | 55 |
| 2011 | 62 |
| 2012 | 69 |
| 2013 | 93 |
| 2014 | 91 |
| 2015 | 74 |
| 2016 | 78 |
| 2017 | 87 |
| 2018 | 118 |
| 2019 | 112 |
| 2020 | 124 |
| 2021 | 148 |
| 2022 | 113 |
| 2023 | 144 |
| 2024 | 136 |
| 2025 | 115 |
| 2026 | 57 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,109 |
| Active, not recruiting | 381 |
| Recruiting | 259 |
| Terminated | 200 |
| Unknown status | 36 |
| Withdrawn | 10 |
| Not yet recruiting | 9 |
| Enrolling by invitation | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 178 |
| AstraZeneca | 149 |
| Hoffmann-La Roche | 145 |
| Sanofi | 104 |
| Merck Sharp & Dohme LLC | 102 |
| Novo Nordisk A/S | 87 |
| Pfizer | 77 |
| Janssen Research & Development, LLC | 68 |
| Eli Lilly and Company | 63 |
| Amgen | 52 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 142 |
| Breast Neoplasms | 87 |
| Diabetes Mellitus, Type 2 | 81 |
| Multiple Myeloma | 49 |
| Neoplasms | 49 |
| Neoplasm Metastasis | 46 |
| Pulmonary Disease, Chronic Obstructive | 44 |
| Hemophilia A | 42 |
| Diabetes Mellitus | 37 |
| Recurrence | 36 |
Trials
Showing 1 to 25 of 2,012. Each trial links to its page on Pharma Observatory.
1,912 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.